We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ensign Group Invests in Growth With New Facility Acquisitions
Read MoreHide Full Article
The Ensign Group, Inc. (ENSG - Free Report) recently announced a series of strategic acquisitions across Washington and California. These acquisitions, effective April 1, 2025, underscore the company’s commitment to expanding its portfolio while optimizing operational efficiency.
Through its real estate subsidiary, Standard Bearer Healthcare REIT, Inc., Ensign Group acquired the real estate of Emilie Court Assisted Living in Spokane, WA, and Mother Joseph Care Center in Olympia, WA. These facilities will be operated by third-party providers under long-term triple-net leases, ensuring stable rental income while leveraging external expertise.
In California, Ensign Group expanded its direct operations by acquiring Pacific Haven Subacute and Healthcare Center in Garden Grove, as well as the operations of Alamitos West Health and Rehabilitation and Katella Senior Living Community in Los Alamitos. This move strengthens the company’s presence in one of its most established markets, enhancing operational efficiencies and service quality.
These strategic acquisitions offer multiple benefits for Ensign Group. Increasing its real estate holdings enhances financial stability and provides additional revenue streams. Strengthening its presence in mature markets improves brand recognition and patient referrals. Additionally, leasing properties to third-party operators allows Ensign Group to diversify its business model while maintaining long-term control over valuable assets.
With these recent acquisitions, Ensign Group now operates 343 healthcare facilities across 17 states. This expansion sets the foundation for sustained growth and operational excellence, positioning Ensign Group as a leader in the healthcare services industry.
ENSG’s Share Price Performance & Zacks Rank
Shares of Ensign Group have gained 9% in the past year compared with the industry’s 1.9% growth. ENSG currently carries a Zacks Rank #2 (Buy).
Option Care’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 15.91%. The consensus estimate for OPCH’s 2025 earnings and revenues indicates an improvement of 37.4% and 8.9%, respectively, from the 2024 figures.
The consensus estimate for Option Care’s earnings has moved 34.1% north in the past 30 days.
ADMA Biologics’ earnings outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark once, the average surprise being 32.80%. The consensus estimate for ADMA’s 2025 earnings and revenues implies an improvement of 44.9% and 16.3% from the respective 2024 figures.
The consensus estimate for ADMA Biologics’ 2025 earnings has moved 1.4% north in the past seven days.
Bioventus’ earnings outpaced the Zacks Consensus Estimate in three of the trailing four quarters and matched the mark once, the average surprise being 119.53%. The consensus estimate for BVS’ 2025 earnings indicates an improvement of 34.7% from the 2024 figure.
The consensus estimate for Bioventus’ 2025 earnings has moved 43.5% north in the past seven days.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Ensign Group Invests in Growth With New Facility Acquisitions
The Ensign Group, Inc. (ENSG - Free Report) recently announced a series of strategic acquisitions across Washington and California. These acquisitions, effective April 1, 2025, underscore the company’s commitment to expanding its portfolio while optimizing operational efficiency.
Through its real estate subsidiary, Standard Bearer Healthcare REIT, Inc., Ensign Group acquired the real estate of Emilie Court Assisted Living in Spokane, WA, and Mother Joseph Care Center in Olympia, WA. These facilities will be operated by third-party providers under long-term triple-net leases, ensuring stable rental income while leveraging external expertise.
In California, Ensign Group expanded its direct operations by acquiring Pacific Haven Subacute and Healthcare Center in Garden Grove, as well as the operations of Alamitos West Health and Rehabilitation and Katella Senior Living Community in Los Alamitos. This move strengthens the company’s presence in one of its most established markets, enhancing operational efficiencies and service quality.
These strategic acquisitions offer multiple benefits for Ensign Group. Increasing its real estate holdings enhances financial stability and provides additional revenue streams. Strengthening its presence in mature markets improves brand recognition and patient referrals. Additionally, leasing properties to third-party operators allows Ensign Group to diversify its business model while maintaining long-term control over valuable assets.
With these recent acquisitions, Ensign Group now operates 343 healthcare facilities across 17 states. This expansion sets the foundation for sustained growth and operational excellence, positioning Ensign Group as a leader in the healthcare services industry.
ENSG’s Share Price Performance & Zacks Rank
Shares of Ensign Group have gained 9% in the past year compared with the industry’s 1.9% growth. ENSG currently carries a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Other Stocks to Consider
Some other top-ranked stocks from the Medical space are Option Care Health, Inc. (OPCH - Free Report) , ADMA Biologics, Inc. (ADMA - Free Report) and Bioventus Inc. (BVS - Free Report) . While Option Care sports a Zacks Rank #1 (Strong Buy) at present, ADMA Biologics and Bioventus carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Option Care’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 15.91%. The consensus estimate for OPCH’s 2025 earnings and revenues indicates an improvement of 37.4% and 8.9%, respectively, from the 2024 figures.
The consensus estimate for Option Care’s earnings has moved 34.1% north in the past 30 days.
ADMA Biologics’ earnings outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark once, the average surprise being 32.80%. The consensus estimate for ADMA’s 2025 earnings and revenues implies an improvement of 44.9% and 16.3% from the respective 2024 figures.
The consensus estimate for ADMA Biologics’ 2025 earnings has moved 1.4% north in the past seven days.
Bioventus’ earnings outpaced the Zacks Consensus Estimate in three of the trailing four quarters and matched the mark once, the average surprise being 119.53%. The consensus estimate for BVS’ 2025 earnings indicates an improvement of 34.7% from the 2024 figure.
The consensus estimate for Bioventus’ 2025 earnings has moved 43.5% north in the past seven days.